• News
    • Events
    • Press Releases
  • Careers
  • Contact Us
Homepage
  • Home
    • About Us
      • Overview
      • Management
      • Board of Directors
      • Scientific Advisory Board
      • Careers
    • Product
      • Overview
      • RIZAPORT®
      • Tadalafil
      • Loxapine
      • Montelukast
      • More Products
    • R&D Services
      • Overview
      • VersaFilm
      • VetaFilm
      • Services
    • Manufacturing Services
      • Overview
      • Manufacturing & Packaging
      • Services
    • Partnering
      • Overview
      • Trade Shows
      • BD Contacts
    • Investors
      • Overview
      • Shareholder Reports
      • Corporate Governance
      • Press Releases
      • Stock Price
      • Presentations
      • Regulatory Filings
      • XBRL Files
      • Analyst Coverage
      • Videos
      • RSS Feeds
      • IR Contact
  • Home
    • About Us
      • Overview
      • Management
      • Board of Directors
      • Scientific Advisory Board
      • Careers
    • Product
      • Overview
      • RIZAPORT<sup>®</sup>
      • Tadalafil
      • Loxapine
      • Montelukast
      • More Products
    • R&D Services
      • Overview
      • VersaFilm
      • VetaFilm
      • Services
    • Manufacturing Services
      • Overview
      • Manufacturing & Packaging
      • Services
    • Partnering
      • Overview
      • Trade Shows
      • BD Contacts
    • Investors
      • Overview
      • Shareholder Reports
      • Corporate Governance
      • Press Releases
      • Stock Price
      • Presentations
      • Regulatory Filings
      • XBRL Files
      • Analyst Coverage
      • Videos
      • RSS Feeds
      • IR Contact
INTELGENXHome  >  Investors  >  Press Releases
INTELGENXHome  >  Investors  >  Press Releases
Normal
2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Cannasat Therapeutics and IntelGenx Enter into a Collaborative Agreement to Develop Novel Cannabinoid-based Products Based on Proprietary Drug Delivery Technologies November 14, 2006
Completed $1.35 million private placement April 28, 2006
  • Home
    • About Us
      • Overview
      • Management
      • Board of Directors
      • Scientific Advisory Board
      • Careers
    • Product
      • Overview
      • RIZAPORT®
      • Tadalafil
      • Loxapine
      • Montelukast
      • More Products
    • R&D Services
      • Overview
      • VersaFilm
      • VetaFilm
      • Services
    • Manufacturing Services
      • Overview
      • Manufacturing & Packaging
      • Services
    • Partnering
      • Overview
      • Trade Shows
      • BD Contacts
    • Investors
      • Overview
      • Shareholder Reports
      • Corporate Governance
      • Press Releases
      • Stock Price
      • Presentations
      • Regulatory Filings
      • XBRL Files
      • Analyst Coverage
      • Videos
      • RSS Feeds
      • IR Contact

Shareholder Tools

Financial Reports E-mail Alerts RSS News Feeds

About us

  • Overview
  • Management
  • Board of Directors
  • Careers

Product

  • Overview
  • RIZAPORT®
  • Tadalafil
  • Loxapine
  • Montelukast
  • More Products

R&D Services

  • Overview
  • VersaFilm®
  • Services

Manufacturing Services

  • Overview
  • Film Manufacturing
  • Services

Partnering

  • Overview

Investors

  • Overview
  • Financial Reports
  • Corporate Governance
  • Press Releases
  • Stock Price
  • Presentations
  • Regulatory Filings
  • Analyst Coverage
  • IR Contact

More Links

  • Facebook
  • Twitter
  • Linkedin
  • Contact us
  • Careers
  • Email Signup
  • RSS Feeds
© Copyright 2019. IntelGenx Corp. All Rights Reserved.
  • Terms of Service
  • Privacy
  • Contact Us
Powered By Q4 Inc. 5.24.1.3